Pill to tackle multiple sclerosis in children delivers ‘some of most promising results ever seen’
A new pill can reduce the symptoms of multiple sclerosis (MS) among children and teenagers, a study has found. Sufferers aged between 10 and 17 who were treated with Gilenya
Read More